Nemaura Medical Inc (NASDAQ: NMRD) Has announced the development of the world's first non-invasive wearable lactic acid
April 23 2019 - 7:00AM
InvestorsHub NewsWire
Nemaura
Medical
Inc
(NASDAQ: NMRD) Has announced the
development of the world's
first non-invasive
wearable lactic
acid monitor.
April 23, 2019
-- InvestorsHub NewsWire -- Equity analytica http://equityanalytica.co.uk
-- Further,
we are pleased to say that the company is no longer over reliant on
its glucose monitoring system for revenue.
Nemaura
Medical Inc.,
a medical device company revolutionising
non-intrusive
glucose
monitoring,
has
announced the development of a new product.
The much coveted wearable real time
monitoring
device which has been developed
from
its flagship
product
SugarBeat
by
revamping the original design to monitor the user's lactic acid
levels,
results
will be instantly transmitted directly to the user's
smartphones.
Nemaura
is the world's first company in the non-invasive lactic acid
monitoring market and is poised to establish itself as a world
leader in
personal fitness monitoring
devices.
Why is this important?
Nemaura
is the first company
in this
arena(1)
and the current market size for
wearable's
is currently over $19.6b and is estimated to exceed $65b by
2023(1).
The new device and app tell you how hard your body is
working
in real time and further show
real time recovery by monitoring lactic acid levels.
As the device is a consumer product, it does not require
regulatory
approval(2)
in any world market and can potentially get to market in months
dependant on the distribution model the company selects.
The product has
multiple
applications and advantages in industries such as;
1. Gym, sports, hiking
& at home.
2.
At
work in many industries.
3. Trucking industry to ensure drivers are not over
working.
4. Military & Law enforcement.
5. General wellbeing & many more.
6. Clothing
and apparel
integration.
The
company is still on
track for its glucose
monitoring device development
timeline
and
we will advise the market of any updates.
This stock is poised for a long a prosperous run and may even end
up north of $15.00. There is no ceiling or limitation to the market
size for this product.
References
-
4/19/2019 8K
Filings NMRD
-
FDA.GOV
(General
Wellness: Policy for Low Risk Devices)
https://allnewsstories.com/2019/04/23/nemaura-medical-inc-nasdaq-nmrd-announced-the-development-of-worlds-first-non-invasive-wearable-lactic-acid-monitor/
SOURCE: Equity
analytica
research@equityanalytica.co.uk
http://equityanalytica.co.uk
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Sep 2023 to Sep 2024